Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTRA
NTRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTRA News
Natera Initiates SIGNAL-ER 101 Study for Early-Stage Breast Cancer
2d ago
NASDAQ.COM
Natera Partners with Diakonos to Evaluate New Therapy
1d ago
Newsfilter
Natera Launches SIGNAL-ER 101 Trial for Breast Cancer Treatment De-escalation
2d ago
Newsfilter
Natera Enhances Panorama NIPT with Low Fetal Fraction Technology
4d ago
Newsfilter
FDA Approves Tecentriq for Bladder Cancer Treatment
May 15 2026
seekingalpha
Natera Receives FDA Approval for Personalized MRD Testing
May 15 2026
Newsfilter
Natera Reports Q1 Results Exceeding Revenue Expectations with 38.8% Growth
May 12 2026
Yahoo Finance
Natera Reports 39% Revenue Growth in Q1 2026
May 08 2026
seekingalpha
Natera Q1 Earnings Beat Expectations with Strong Revenue Growth
May 07 2026
seekingalpha
Strait of Hormuz Reopening Boosts Healthcare Stocks
Apr 18 2026
Yahoo Finance
Latest Rating Changes on Wall Street
Apr 14 2026
CNBC
Natera Wins Patent Dispute, Secures 30% Ongoing Royalty
Apr 09 2026
seekingalpha
Natera Wins Patent Litigation Update with 30% Ongoing Royalty
Apr 09 2026
Newsfilter
Natera Showcases Advances in AI-Driven Genomics at AACR Annual Meeting
Apr 07 2026
Newsfilter
Natera's Signatera Study Published in Clinical Cancer Research
Mar 31 2026
Yahoo Finance
Signatera Enables Surgery Avoidance for Women Over 70
Mar 31 2026
Newsfilter
Show More News
